Navigation Links
Dragon Pharma reports 2010 first quarter financial results
Date:5/17/2010

lings may be obtained by directing a request to Dragon Pharmaceutical, Inc., 650 West Georgia Street, Suite 310, Vancouver, British Columbia, Canada V6B 4N9 Attention: Maggie Deng, Secretary.

The Company and certain of its directors, executive officers and other members of management and employees may, under SEC rules, be deemed to be "participants" in the solicitation of proxies from our stockholders with respect to the proposed merger. Information regarding the persons who may be considered "participants" in the solicitation of proxies will be set forth in our proxy statement relating to the proposed merger when it is filed with the SEC. Information regarding certain of these persons and their beneficial ownership of our common stock as of March 15, 2010, is set forth in our preliminary proxy statement which was filed with the SEC on April 1, 2010. Additional information regarding the interests of such potential participants will be included in the proxy statement and the other relevant documents filed with the SEC when they become available.

About Dragon Pharmaceutical Inc.

Dragon Pharmaceutical, incorporated in Florida and headquartered in Vancouver, Canada, is a leading manufacturer and distributor of a broad line of high-quality antibiotic products including Clavulanic Acid and 7-ACA, a key intermediate to produce cephalosporin antibiotics and formulated drugs. Dragon Pharma is the third largest 7-ACA producer and the dominant manufacturer and market leader of Clavulanic Acid products in China. Dragon Pharma utilizes its nationwide sales distribution network, close customer relationships, understanding of local markets and customer needs and low
'/>"/>

SOURCE Dragon Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
2. Strong Demand Pushes up Both Prices and Sales Volumes for Dragons Main Products
3. Dragon Announces R&D Achievement in Biotech Manufacturing Process
4. Dragon announces new product launch; increase in annual production output capacity
5. Dragon retains leading investor relations firm
6. Dragon Pharma announces 2007 full year financial results
7. 3SBio Inc. to Present at The Oppenheimer 2nd Annual China Dragon Call Conference
8. Dragon Pharma Announces June 26, 2008 for 2008 Annual Shareholders Meeting
9. Dragon Pharma Announces Results of the Annual General Meeting
10. Dragon to Present at BioContact Quebec 2008
11. China Biologic Products to Present at CCG IRs China Rising Conference and Oppenheimers China Dragon Call Conference in New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire/ - iCo Therapeutics ... today reported financial results for the six months ... are expressed in Canadian dollars and presented under ... Quarter 2014 Highlights , Announced top-line ... (VA) primary endpoint for subjects enrolled in the ...
(Date:8/29/2014)... 2014 Three Lawrence Livermore researchers ... Hydrogen Production R&D Award for their research ... using sunlight. , Shared with collaborators from the ... of Nevada, Las Vegas (UNLV), the award recognizes ... photoelectrochemical solar-hydrogen production and corrosion processes. , These ...
(Date:8/29/2014)... 2014 A major challenge before new ... dense realm of Boston-Cambridge, is gaining visibility that can ... Sherley, the Director of Boston’s Adult Stem Cell Technology ... national visibility of his company an important priority since ... addition to a social media marketing campaign ...
(Date:8/28/2014)... SAN DIEGO, California, USA (PRWEB) August 28, 2014 ... at the Department of Physics and Optical Science and ... at the University of North Carolina at Charlotte, and ... has been elected to serve as the 2015 Vice ... photonics. , SPIE 2014 President Philip Stahl announced recent ...
Breaking Biology Technology:iCo Therapeutics Announces Second Quarter 2014 Financial Results 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 3iCo Therapeutics Announces Second Quarter 2014 Financial Results 4Livermore Team Awarded for Hydrogen Production Research 2The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 2The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 3The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 4Glenn Boreman, UNC Professor and Plasmonics Co-Founder, Elected to SPIE Presidential Chain 2
... ... specifically established to treat adolescents and adults and is today the largest of its kind ... , ... The Hertz Family Foundation of Santa Monica has announced that total contributions now exceed $2 ...
... , Opinion ... , WASHINGTON, Dec. 9 On Tuesday, December 8, 2009, ... The Decade-2 Education Forum in Washington, ... to America,s students and was sponsored by Amgen , a leading biotechnology ...
... Tenn., Dec. 9 Cumberland Pharmaceuticals Inc. (Nasdaq: ... agreement with DB Pharm Korea Co. Ltd. , a Korean-based ... in South Korea. Designed to treat pain and fever in the ... Administration and launched by Cumberland in the United States earlier this ...
Cached Biology Technology:Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 2Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 3Science Education Experts Discuss Solutions for Global Competitiveness at Scientific American Forum 2Science Education Experts Discuss Solutions for Global Competitiveness at Scientific American Forum 3Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 2Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 3Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 4
(Date:8/28/2014)... is now available from the Lady Bird Johnson Wildflower ... identifying harmful non-native plant, insect and other invasive species ... cause about $137 billion in economic and other damage ... native plants and more. , "By having streamlined tools ... species occur, we,re more likely to catch these threats ...
(Date:8/28/2014)... your neighbors than traditional cigarettes, but still release ... study from USC. , Scientists studying secondhand smoke ... exposure to harmful particles, with close-to-zero exposure to ... harmful metals in second-hand e-cigarette smoke were found ... contains high levels of polycyclic aromatic hydrocarbons ...
(Date:8/28/2014)... Ga. The support of peer groups and ... breastfeeding programs, according to recent University of Georgia ... in the Athens-Clarke County area determined that role ... outcomes of mothers of infants. , "Mothers who ... successful at breastfeeding," said study co-author Alex Anderson, ...
Breaking Biology News(10 mins):Mobile app makes ID of harmful plants, insects in Texas a snap 2Second-hand e-cig smoke compared to regular cigarette smoke 2Breastfeeding study shows need for effective peer counseling programs 2
... For clinicians, the ability to look routinely inside the body ... how it confronts disease is a distant dream. But in ... of researchers from the Howard Hughes Medical Institute (HHMI) at ... step toward realizing that vision by demonstrating the ability to ...
... insect forms—beetles, flies, dragonflies, mosquitoes, grasshoppers, ants, wasps, bees, ... all species known. The large number of insect species ... or more factors: a high rate of formation of ... new environments and exploit new ecological niches, and a ...
... No matter how healthy a life one leads, no person ... though the advances of the modern age may have extended ... genetic limits to longevity. One prominent theory of aging lays ... and proteins by “free radicals,?highly reactive molecules produced by the ...
Cached Biology News:Jefferson biologist coaxing human embryonic stem cells to make dopamine with simpler, faster method 2Jefferson biologist coaxing human embryonic stem cells to make dopamine with simpler, faster method 3Islands in the Genome Promote Speciation 2Navigating the brain for sense of direction as paradigm for higher cognitive functions 2
Automated Cell Culture Flask...
... high-throughput fluidics (HTF) system, 100-240 V, is ... array system that automates delivery of up ... the Bio-Plex array reader. The HTF system ... bulk sheath container to constantly maintain a ...
... laboratory, the revolutionary Luminex 100 System delivers ... in real time enhancing your operational efficiency. ... the Luminex 100, the XY Platform, and ... enables you to simultaneously assay up to ...
... This gradient system is ideal for routine binary ... highly sensitive Adept CE 4201 UV-Visible variable wavelength ... is provided by the two highly accurate ... CE 4100 solvent delivery pumps., Chromatograms may be ...
Biology Products: